HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs.

Abstract
The clinical course of Cystic Fibrosis is characterized by recurrent pulmonary infections which ultimately lead to death by respiratory failure. The most common CF causing mutation, deltaF508-CFTR, produces an incorrectly folded protein, which accumulates within the endoplasmic reticulum. However, the molecular mechanism by which the deltaF508-CFTR protein facilitates pulmonary infection and inflammation remains unclear. Here we show that the expression of deltaF508-CFTR causes a constitutive activation of the pro-inflammatory transcription factor NF-kappaB by eliciting an ER stress reaction, the ER-overload response. This endogenous NF-kappaB activation stimulates the transcription of pro-inflammatory cytokines thereby commencing an inflammatory cascade within the CF lung.
AuthorsAlexander Knorre, Mathias Wagner, Hans-Eckart Schaefer, William H Colledge, Heike L Pahl
JournalBiological chemistry (Biol Chem) Vol. 383 Issue 2 Pg. 271-82 (Feb 2002) ISSN: 1431-6730 [Print] Germany
PMID11934265 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CFTR protein, human
  • NF-kappa B
  • cystic fibrosis transmembrane conductance regulator delta F508
  • Cystic Fibrosis Transmembrane Conductance Regulator
Topics
  • Animals
  • Cell Line
  • Cystic Fibrosis (complications, genetics, metabolism)
  • Cystic Fibrosis Transmembrane Conductance Regulator (genetics)
  • Disease Models, Animal
  • Endoplasmic Reticulum (metabolism)
  • Humans
  • Lung (metabolism, ultrastructure)
  • Mice
  • Mice, Inbred CFTR
  • NF-kappa B (biosynthesis)
  • Transcriptional Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: